Research: CHEN and others,

Listed in Issue 140

Abstract

CHEN and others, Department of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan, have studied the effects of soya protein on the fat profile of people with elevated cholesterol.

Background

Clinical trials have shown that soya protein reduces the concentrations of some atherogenic lipids in subjects with normal renal function. The aim of this study was to examine the effects of soya protein on serum lipid concentrations and lipoprotein metabolism in hypercholesterolaemic patients on haemodialysis.

Methodology

26 high-cholesterol patients on haemodialysis were studied in a randomized, double-blind, placebo-controlled clinical trial. After a 4-week run-in phase, the subjects were randomly assigned to two groups. Isolated soya protein or milk protein 30 g was consumed daily as a beverage at breakfast for 12 weeks.

Results

Soya protein substitution resulted in significant reductions in total cholesterol (17.2%), LDL-cholesterol (15.3%), apo B (14.6%) and insulin (23.8%) concentrations. There were no significant changes in HDL-cholesterol or apo A-I.

Conclusion

These results indicate that replacing part of the daily protein intake with soya protein has a beneficial effect on atherogenic lipids and may reduce the risk of cardiovascular disease.

References

Chen ST, Chen JR, Yang CS, Peng SJ, Ferng SH. Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis. British Journal of Nutrition 95 (2): 366-371, Feb 2006.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page